PATENT CLAIM ANALYSIS

Application Number: 15984855
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["544", "283000"]

Abstract:
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

Claim (Index 15):
The compound of  claim 1  having the structure or the stereoisomer thereof, the atropisomer thereof, the pharmaceutically acceptable salt thereof, the pharmaceutically acceptable salt of the stereoisomer thereof, or the pharmaceutically acceptable salt of the atropisomer thereof.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.44444
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15849905', '15938001', '15829541', '14735254', '11710582']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7844094500759985
- 35 USC 102 Novelty (BERT): 0.507624899847198
- Combined Prediction Score: 0.7567309950531185
- Mean Citation Score: 305.186724
- Max Citation Score: 338.83557
- Similarity Product: 287.8609120694876

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test